Michael Schöll

This study uses chemical imaging and deep learning to identify distinct amyloid plaque subtypes in Alzheimer's disease, revealing differences in Aβ composition and associations with disease progression.

The paper examines the effect of APOE ε4 gene dose on glial reactivity and β-amyloid pathology in cognitively unimpaired individuals using PET, MRI, and plasma biomarkers.

This paper develops bispecific antibodies targeting multiple pathological targets in tauopathies and shows they inhibit aggregation and complement pathway activation.

This study uses data-driven clustering to identify spatial patterns of tau-PET distribution in Alzheimer’s disease and compares them to pathology-driven ROIs, finding two clusters with strong cognitive associations.